{
  "report_rows": [
    {
      "kpi": "Q2 2026 net sales",
      "prediction": "BEAT",
      "answer": "pred ~$1.83B vs. cons $1.81B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q2 2026 operating EBITDA",
      "prediction": "BEAT",
      "answer": "pred ~$438M vs. cons $430M",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q2 2026 adjusted EPS",
      "prediction": "BEAT",
      "answer": "pred ~$1.82 vs. cons $1.79",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "Net sales guidance",
      "prediction": "BETTER",
      "answer": "guide ~$7.23B midpoint vs. cons $7.175B (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Operating EBITDA guidance",
      "prediction": "BETTER",
      "answer": "guide ~$1.775B midpoint vs. cons $1.752B (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Adjusted EPS guidance",
      "prediction": "BETTER",
      "answer": "guide ~$7.25 midpoint vs. cons $7.16 (FY2026)",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": 3.2,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": 4.0,
  "day5_path": "FOLLOW-THROUGH",
  "day5_rationale": "A modest FY2026 raise\u2014particularly adjusted EPS of ~$7.25 versus consensus of $7.16 and operating EBITDA of ~$1.775B versus $1.752B\u2014should drive positive estimate revisions beyond the initial Q2 beat, supporting additional five-day appreciation.",
  "day5_confidence": "MEDIUM"
}